Trial ID or NCT#



not recruiting iconNOT RECRUITING


This is a randomized, controlled, double-blind, placebo-controlled trial of intranasal Avastin (bevacizumab) injection versus saline control for control of HHT-related epistaxis when used in conjunction with bipolar electrocautery.

Official Title

Intranasal Bevacizumab for HHT-Related Epistaxis

Eligibility Criteria

Ages Eligible for Study: Older than 18 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No


Peter H. Hwang
Peter H. Hwang
Head and neck surgeon, Otolaryngologist, Rhinologist
Professor of Otolaryngology - Head & Neck Surgery (OHNS) and, by courtesy, of Neurosurgery

Contact us to find out if this trial is right for you.


Amelia K Clark, MD